These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11831978)

  • 41. MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?
    Castellani MR; Seregni E; Maccauro M; Chiesa C; Aliberti G; Orunesu E; Bombardieri E
    Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):430-40. PubMed ID: 19088696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Review analysis of medullary carcinoma thyroid--15-year Indian experience.
    Dorairajan N; Saravanakumar P; Karthikeyan S; Siddharth D; Kanna S
    J Indian Med Assoc; 2005 Aug; 103(8):415-7, 427. PubMed ID: 16363195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
    Diez JJ; Iglesias P
    Thyroid; 2004 Nov; 14(11):984-5. PubMed ID: 15678599
    [No Abstract]   [Full Text] [Related]  

  • 44. Gastrin Responses to a test meal in patients with familial medullary thyroid carcinoma.
    O'Dorisio TM; Falko JM; Cataland S; Almoney RW; George JM; Mazzaferri EL; Reynolds JC
    J Clin Endocrinol Metab; 1982 Apr; 54(4):798-802. PubMed ID: 7061688
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Use of thyrocalcitonin for the detection of familial medullary cancers in children].
    Calmettes C
    Ann Med Interne (Paris); 1984; 135(5):335-7. PubMed ID: 6486612
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reoperation for recurrent or persistent medullary thyroid cancer.
    Moley JF; Wells SA; Dilley WG; Tisell LE
    Surgery; 1993 Dec; 114(6):1090-5; discussion 1095-6. PubMed ID: 8256212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medullary thyroid carcinoma.
    Evans DB; Burgess MA; Goepfert H; Gagel RF
    Curr Ther Endocrinol Metab; 1997; 6():127-32. PubMed ID: 9174720
    [No Abstract]   [Full Text] [Related]  

  • 48. Intraoperative calcitonin stimulation testing in the surgical treatment of C-cell disease.
    Obtulovicova K; Sicak M; Kalis A; Vanuga A; Putz Z; Vanuga P; Pura M; Obtulovic M
    Neuro Endocrinol Lett; 2017 Nov; 38(Suppl1):11-17. PubMed ID: 29200250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Somatostatin receptor imaging in persistent medullary thyroid carcinoma.
    Frank-Raue K; Bihl H; Dörr U; Buhr H; Ziegler R; Raue F
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):31-7. PubMed ID: 7889629
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The determination of calcitonin for hospital use (author's transl)].
    Raue F; Minne H; Schäfer D; Ziegler R
    MMW Munch Med Wochenschr; 1977 Feb; 119(7):219-24. PubMed ID: 403447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. "Hook effect" in calcitonin immunoradiometric assay in patients with metastatic medullary thyroid carcinoma: case report and review of the literature.
    Leboeuf R; Langlois MF; Martin M; Ahnadi CE; Fink GD
    J Clin Endocrinol Metab; 2006 Feb; 91(2):361-4. PubMed ID: 16278263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Markedly elevated serum calcitonin concentrations associated with initial presentation but not the recurrent presentation of medullary thyroid carcinoma.
    Bodenner D; Nalley C; Chien C; Clarke B; Spring PM; Stack BC
    Thyroid; 2010 Aug; 20(8):927-9. PubMed ID: 20677998
    [No Abstract]   [Full Text] [Related]  

  • 53. [Value of the assay of plasma carcinoembryonic antigen and thyrocalcitonin in the detection of medullary cancer of the thyroid with amyloid stroma. Results of a familial survey of 47 subjects].
    Allanic H
    Ann Med Interne (Paris); 1984; 135(5):341-4. PubMed ID: 6486613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved results of cervical reoperation for medullary thyroid carcinoma.
    Moley JF; Dilley WG; DeBenedetti MK
    Ann Surg; 1997 Jun; 225(6):734-40; discussion 740-3. PubMed ID: 9230814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Progress and controversy on the extent of surgery for medullary thyroid carcinoma based on calcitonin levels].
    Xian KY; Liu J
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1755-1758. PubMed ID: 38782745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metastatic medullary thyroid carcinoma in sputum. A light and electron microscopic study.
    Hamilton CW; Bigner SH; Wells SA; Johnston WW
    Acta Cytol; 1983; 27(1):49-53. PubMed ID: 6573830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of early postoperative calcitonin level in medullary thyroid carcinoma.
    Girelli ME; Dotto S; Nacamulli D; Piccolo M; De Vido D; Russo T; Bernante P; Pelizzo MR; Busnardo B
    Tumori; 1994 Apr; 80(2):113-7. PubMed ID: 8016900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Radiation therapy for medullary thyroid carcinoma].
    Isaev PA; Il'in AA; Medvedev VS; Semin DIu; Pol'kin VV; Derbugov DN; Vasil'kov SV; Radzhanova MU; Chebotareva IV
    Vopr Onkol; 2013; 59(6):781-4. PubMed ID: 24624792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated CEA in breast cancer patients with overlooked medullary thyroid carcinoma.
    Andry G; Wildschutz T; Chantrain G; Bonnyns M; Dor P
    Eur J Surg Oncol; 1993 Jun; 19(3):305-8. PubMed ID: 8100201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Assessment of surgical treatments of medullary thyroid carcinoma by analysis of serum calcitonin levels].
    Miyauchi A; Matsuzuka F; Kuma K; Takai S; Maeda M
    Nihon Geka Gakkai Zasshi; 1987 Jan; 88(1):102-8. PubMed ID: 3821708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.